Open AccessOne-Year Results of Treatment of Diabetic Macular Edema with Aflibercept Using the Treat-and-Extend Dosing Regimen: the VIBIM Study
Author(s) -
Kang Yeun Pak,
Jae Pil Shin,
Hyun Woong Kim,
Min Sagong,
Yu Cheol Kim,
Sang Joon Lee,
In Young Chung,
Sung Who Park,
Ji Eun Lee
Publication year - 2020
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000504753
Subject(s) - aflibercept , medicine , diabetic macular edema , regimen , visual acuity , confidence interval , ophthalmology , macular edema , dosing , prospective cohort study , edema , diabetic retinopathy , surgery , diabetes mellitus , bevacizumab , chemotherapy , endocrinology
The purpose of this study was to report the one-year results of treatment of diabetic macular edema (DME) with aflibercept using a treat-and-extend regimen (TER).